247 related articles for article (PubMed ID: 25488826)
1. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolic loci and vitamin D status in Black and White pregnant women.
Baca KM; Govil M; Zmuda JM; Simhan HN; Marazita ML; Bodnar LM
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():61-68. PubMed ID: 29175129
[TBL] [Abstract][Full Text] [Related]
6. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
[TBL] [Abstract][Full Text] [Related]
7. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.
Engelman CD; Fingerlin TE; Langefeld CD; Hicks PJ; Rich SS; Wagenknecht LE; Bowden DW; Norris JM
J Clin Endocrinol Metab; 2008 Sep; 93(9):3381-8. PubMed ID: 18593774
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.
Torkko K; Till C; Tangen CM; Goodman PJ; Song X; Schenk JM; Lucia MS; Peters U; van Bokhoven A; Thompson IM; Neuhouser ML
Cancer Prev Res (Phila); 2020 Jun; 13(6):521-530. PubMed ID: 32102946
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
12. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
[TBL] [Abstract][Full Text] [Related]
14. CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence.
Hibler EA; Klimentidis YC; Jurutka PW; Kohler LN; Lance P; Roe DJ; Thompson PA; Jacobs ET
Nutr Cancer; 2015; 67(7):1131-41. PubMed ID: 26241700
[TBL] [Abstract][Full Text] [Related]
15. Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.
Gilbert R; Metcalfe C; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM; Tilling K
Eur J Cancer Prev; 2013 Mar; 22(2):121-5. PubMed ID: 22955340
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
Clendenen TV; Ge W; Koenig KL; Axelsson T; Liu M; Afanasyeva Y; Andersson A; Arslan AA; Chen Y; Hallmans G; Lenner P; Kirchhoff T; Lundin E; Shore RE; Sund M; Zeleniuch-Jacquotte A
PLoS One; 2015; 10(10):e0140478. PubMed ID: 26488576
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in Type 2 Diabetes: Genetic Susceptibility and the Response to Supplementation.
Klahold E; Penna-Martinez M; Bruns F; Seidl C; Wicker S; Badenhoop K
Horm Metab Res; 2020 Jul; 52(7):492-499. PubMed ID: 32542627
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.
Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Farin FM; Makar KW; Carlson CS; Caan BJ; Potter JD; Peters U
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2540-8. PubMed ID: 19706847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
